Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.

ABSTRACT:

SUBMITTER: MacKenna B 

PROVIDER: S-EPMC9179144 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature